The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19.
作者信息
Ripa Marco, Mastrangelo Andrea
机构信息
Unit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.
出版信息
Chest. 2021 Aug;160(2):387-388. doi: 10.1016/j.chest.2021.04.053.
Abstract
摘要
相似文献
1
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19.
Chest. 2021 Aug;160(2):387-388. doi: 10.1016/j.chest.2021.04.053.
2
Appropriate use of antimicrobial therapy for COVID-19 co-infection.
Immunotherapy. 2021 Sep;13(13):1067-1070. doi: 10.2217/imt-2021-0134. Epub 2021 Jun 11.
3
Could the COVID-19 pandemic aggravate antimicrobial resistance?
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
4
Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19.
Clin Infect Dis. 2021 Jun 1;72(11):e926. doi: 10.1093/cid/ciaa1559.
5
Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
Clin Infect Dis. 2021 May 18;72(10):e542-e544. doi: 10.1093/cid/ciaa1273.
6
COVID-19 pneumonia and the appropriate use of antibiotics.
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454. doi: 10.1016/S2214-109X(20)30444-7. Epub 2020 Nov 11.
7
Antimicrobial prescribing practices at a tertiary-care center in patients diagnosed with COVID-19 across the continuum of care.
Infect Control Hosp Epidemiol. 2021 Jan;42(1):89-92. doi: 10.1017/ice.2020.370. Epub 2020 Jul 24.
8
COVID-19 and Outpatient Parenteral Antimicrobial Therapy.
Ann Intern Med. 2021 Jan;174(1):142. doi: 10.7326/L20-1347.
9
COVID-19 and Outpatient Parenteral Antimicrobial Therapy.
Ann Intern Med. 2021 Jan;174(1):141-142. doi: 10.7326/L20-1346.
10
The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1489. doi: 10.1164/rccm.202107-1656LE.
引用本文的文献
1
The Dynamics of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict Progression to Septic Shock and Death in Patients with Prolonged Intensive Care Unit Stay.
Medicina (Kaunas). 2022 Dec 23;59(1):32. doi: 10.3390/medicina59010032.
2
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19.
Ther Adv Infect Dis. 2022 May 14;9:20499361221095732. doi: 10.1177/20499361221095732. eCollection 2022 Jan-Dec.
本文引用的文献
1
Hospital-Acquired Infections in Critically Ill Patients With COVID-19.
Chest. 2021 Aug;160(2):454-465. doi: 10.1016/j.chest.2021.04.002. Epub 2021 Apr 20.
2
Methodological quality of COVID-19 clinical research.
Nat Commun. 2021 Feb 11;12(1):943. doi: 10.1038/s41467-021-21220-5.
3
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
Chest. 2021 Mar;159(3):933-948. doi: 10.1016/j.chest.2020.09.275. Epub 2020 Oct 17.
4
A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit.
Clin Infect Dis. 2021 Oct 5;73(7):e1634-e1644. doi: 10.1093/cid/ciaa1298.
5
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
6
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
7
SARS-CoV-2 and viral sepsis: observations and hypotheses.
Lancet. 2020 May 9;395(10235):1517-1520. doi: 10.1016/S0140-6736(20)30920-X. Epub 2020 Apr 17.
8
POINT: Should Broad-Spectrum Antibiotics Be Routinely Administered to All Patients With Sepsis as Soon as Possible? Yes.
Chest. 2019 Oct;156(4):645-647. doi: 10.1016/j.chest.2019.05.030.
9
International study of the prevalence and outcomes of infection in intensive care units.
JAMA. 2009 Dec 2;302(21):2323-9. doi: 10.1001/jama.2009.1754.
Zotero 插件